Polly

Parrots Inc. is working to solve the pressing problem of inadequate care and support for patients with neurological disorders and their caregivers. This challenge affects millions of people globally, both directly (the patients) and indirectly (their caregivers and families).

Globally, over 1 billion people are affected by neurological disorders, including Parkinson's disease, Alzheimer's, multiple sclerosis, and ALS, among others. This represents around 1 in 6 of the world population. According to the World Health Organization, neurological disorders are the leading cause of disability and the second leading cause of death worldwide.

Caregivers of patients with neurological disorders face significant challenges as well, often experiencing physical, emotional, and financial strain. A study in the United States found that 53% of caregivers report high emotional stress, and 38% report high physical strain.

The factors contributing to this problem include:

1. The complexity of neurological disorders: Patients with neurological disorders often exhibit a wide range of symptoms that evolve and progress over time, making it difficult to manage their condition effectively.
2. Limited access to specialized care: Many patients and caregivers lack access to appropriate medical resources and support, especially in rural or underserved communities. This leads to delays in diagnosis, treatment, and rehabilitation.
3. Fragmented care: Current solutions often address only a single aspect of the patient's needs, leaving them to juggle multiple devices, applications, and therapies.
4. High costs of care and support: The financial burden associated with neurological disorders can be overwhelming for patients and their families, limiting their access to the resources they need.

Parrots Inc. addresses these factors through Polly, an AI-driven platform that combines multiple therapies and support tools in a single, user-friendly solution. By offering a comprehensive approach to care and support for patients with neurological disorders and their caregivers, we aim to improve the quality of life, ease the burden on caregivers, and enhance the overall care experience.

Our solution is Polly, an AI-driven platform designed to improve the lives of patients with neurological disorders and their caregivers. Polly is an AI/ML-powred comprehensive platform, an easy-to-use tool that combines multiple therapies, cognitive support, and telehealth features in one unified platform.

Here's how Polly works:

1. Comprehensive Care: Polly integrates various therapeutic approaches, such as voice therapy, physical therapy, cognitive training, and medication management, into one seamless platform. This allows patients and caregivers to access all necessary resources in one place, making it easier to manage the patient's condition.

2. AI-driven Personalization: Polly's AI algorithms analyze the patient's needs, preferences, and progress, and create a personalized care plan. This ensures that the platform delivers the most effective and relevant interventions to each individual user.

3. Telehealth Features: Polly offers telehealth capabilities, enabling patients to consult with healthcare professionals remotely. This reduces the need for frequent in-person visits, saving time and reducing the carbon footprint associated with travel.

4. Support for Caregivers: Polly provides caregivers with resources, tools, and insights to better understand and manage the patient's condition. This support empowers caregivers and reduces their burden, leading to better patient outcomes.

5. Data Analytics and Reporting: Polly collects and analyzes data on patient progress and therapy effectiveness. This information is presented through clear and actionable reports, helping healthcare professionals make informed decisions and adjust treatment plans as needed.

By leveraging AI and telehealth technologies, Polly provides a holistic, personalized, and environmentally friendly solution to improve the quality of life for patients with neurological disorders and their caregivers.

Our solution serves two primary groups: patients with neurological disorders and their caregivers. The target population includes individuals diagnosed with Parkinson's disease, Alzheimer's disease, multiple sclerosis, and other neurological conditions. These patients often require continuous care and management to maintain their quality of life. Caregivers, who are usually family members or friends, play a crucial role in providing support and assistance but often lack the resources and knowledge necessary to manage these complex conditions effectively.

Currently, patients and caregivers face several challenges:

1. Fragmented care: Accessing multiple therapies and services requires considerable time and effort, with patients and caregivers needing to navigate a complex web of appointments, medications, and therapies.

2. Limited personalization: Existing solutions often follow a one-size-fits-all approach, which may not address the unique needs of each patient.

3. Inadequate caregiver support: Caregivers often lack the necessary resources and training to effectively manage the patient's condition, leading to increased stress and burnout.

4. Environmental impact: Frequent in-person visits to healthcare providers contribute to a larger carbon footprint due to transportation.

Our solution, Polly, addresses these challenges by:

1. Unifying care: By integrating multiple therapies, support services, and telehealth features into one platform, Polly simplifies care management for patients and caregivers, streamlining their experience and reducing stress.

2. AI-driven personalization: Polly's AI algorithms create personalized care plans tailored to each patient's unique needs, preferences, and progress, ensuring the most effective interventions are delivered, resulting in better patient outcomes.

3. Empowering caregivers: Polly provides caregivers with resources, tools, and insights to better understand and manage the patient's condition, reducing their burden, and improving patient care.

4. Enhancing communication: Polly facilitates seamless communication between patients, caregivers, and healthcare professionals, improving collaboration and decision-making.

5. Reducing the carbon footprint: By offering telehealth capabilities, Polly decreases the need for frequent in-person visits, saving time and reducing the environmental impact associated with travel.

6. Scalability: Polly's cloud-based infrastructure enables rapid deployment and easy access to a wide range of patients and caregivers, regardless of their geographical location.

By addressing these needs, Polly directly and meaningfully improves the lives of patients with neurological disorders and their caregivers, providing them with a comprehensive, personalized, and environmentally conscious solution for care management. This innovative approach ensures a more efficient, effective, and sustainable way to manage neurological disorders, benefiting individuals, families, and communities around the world.

Our team at Parrots Inc is uniquely positioned to deliver this solution, as we possess not only extensive technical expertise but also a deep understanding and empathy for the communities we serve. Our team comprises accomplished professionals with diverse skill sets:

• David Hojah, studied Engineering and Health Management at Harvard, with over 16 years of experience in robotics, drones, medical devices, NeuroTech, assistive technology, and TeleHealth.
• Glenn Eaton, MIT Electrical & CS Eng. BS, with 31+ years of experience in Electrical Engineering, telecommunications, devices, CS, coding, MedTech, and robotics.
• Priyanka Ray, MIT Design/CS Engineering MS, with 18+ years of experience in AI/ML, data analytics, human-computer interaction, coding, cloud computing, and UX/UI.
• Bulent Aslan, MD at Beth Israel Hospital, Boston, with 15+ years of experience in Medical Technology, radiology, treatment, healthcare management, diagnostics, NeuroTech, and medical research.
• Azady Pirhanov, PhD in Biomedical Engineering, with 10+ years of experience in AI/ML, R&D, immunology, MedTech, technology development, and BioTech at Ragon Institute: MGH, MIT, Harvard.
• Dina Zaki, BS in IT and PMP, works at MIT with 21+ years of experience in medical technology, healthcare, business operations, resources, analytics, insurance, IT, funding, and sales.
• Heather Lawver, with 25+ years of experience in marketing, partnerships, sales, human-centric design, grants and content writing, public speaking, fundraising, investments, business, and UX/UI.
• Ilyse Veron, BA from Yale and MBA from Georgetown University, with 30+ years of experience in Age-Tech, policy, marketing, strategies, business analytics, and partnerships.

In addition to our core team members, Parrots Inc also benefits from the guidance of advanced advisers in MedTech, veterans, and age innovation from prestigious institutions like MIT, Harvard, Microsoft, and Google.

Our team's close proximity to the communities we serve and our personal experiences with neurological disorders enable us to better understand the challenges faced by patients and caregivers. We actively engage with these communities, incorporating their input, ideas, and agendas into the development and implementation of our solution. This collaborative approach ensures that our platform, Polly, remains responsive to the evolving needs of patients and caregivers, fostering trust and demonstrating our commitment to providing a solution that truly benefits the communities we serve.

180 users 

We are applying to MIT Solve for several reasons:

1. Access to resources and expertise: MIT Solve has a diverse and knowledgeable network of experts, partners, and resources that can help us address the various barriers we face. By tapping into this network, we hope to gain valuable insights and support to overcome these challenges.

2. Financial support: As a growing startup, securing funding is critical to our success. MIT Solve offers a platform to connect with potential investors and funding opportunities, which could accelerate our growth and impact.

3. Technical guidance: MIT Solve's network includes experts in healthcare, technology, and innovation. We hope to receive technical guidance and mentorship to refine our solution, improve its effectiveness, and ensure that it remains at the cutting edge of medical technology.

4. Market access: MIT Solve can help us establish partnerships and collaborations with key stakeholders, including healthcare providers, insurance companies, and government organizations. These connections can help us expand our market reach, increase adoption, and ultimately scale our impact.

5. Legal and regulatory support: Navigating the complex legal and regulatory landscape of medical technology can be challenging. MIT Solve's network of experts can provide valuable guidance to help us meet these requirements and ensure our solution is compliant and accessible to patients.

6. Cultural sensitivity: To ensure our solution is inclusive and effective for diverse populations, we need to be culturally sensitive in our approach. MIT Solve's focus on diversity, equity, and inclusivity can provide us with valuable insights and guidance to help us better serve the needs of various communities.

7. Peer learning: Being a part of the MIT Solve community will allow us to learn from other innovative solutions and share our own experiences, fostering a collaborative environment to drive meaningful change and impact.

We believe that joining the MIT Solve community will provide us with the support, resources, and connections we need to overcome the barriers we face and accelerate our growth, ultimately enabling us to create a lasting impact on the lives of patients with neurological disorders and their caregivers.

Our solution, Polly, is innovative because it combines several essential aspects of care management for patients with neurological disorders and their caregivers into a single, easy-to-use platform. By leveraging the power of AI and telehealth, Polly streamlines the diagnostic journey, personalizes treatment plans, monitors patient progress, and facilitates remote consultations with healthcare professionals.

This all-in-one approach not only enhances patient care but also reduces the burden on caregivers and healthcare systems. It also addresses the fragmentation and inefficiencies in current care models for neurological disorders. Our platform's seamless integration of multiple functions encourages other players in the healthcare space to adopt similar comprehensive solutions, ultimately improving the overall standard of care for patients with complex health conditions.

By offering a powerful and efficient care management tool, Polly has the potential to change the market dynamics in the neurological disorder space, shifting the focus from isolated solutions to a more holistic approach. This shift will enable better collaboration between healthcare providers, patients, and caregivers, ultimately improving health outcomes and the overall quality of life for individuals affected by neurological disorders.

Over the next year, our impact goals for Parrots Inc. include:

1. Expanding our user base to serve 10,000 patients with neurological disorders and their caregivers, improving their access to personalized care and reducing the time to accurate diagnosis.
2. Establishing partnerships with at least 20 major healthcare providers and clinics to integrate Polly into their care management systems, increasing the availability of our solution to a wider audience.
3. Conducting ongoing research and development to refine and enhance Polly's AI capabilities, further personalizing the user experience and optimizing treatment plans.

In the next five years, we aim to achieve the following impact goals:

1. Significantly scale our user base, reaching over 100,000 patients with neurological disorders and their caregivers, drastically improving their care management experiences and health outcomes.
2. Expand our presence globally, collaborating with healthcare providers and governments in at least 50 countries, ensuring that our innovative solution reaches underserved communities worldwide.
3. Foster a supportive ecosystem of healthcare professionals, researchers, and technology experts working in the neurological disorder space, driving innovation and knowledge sharing to advance the field and improve patient care.

To achieve these goals, we plan to:

1. Invest in targeted marketing and outreach efforts to raise awareness of our solution and its benefits for patients, caregivers, and healthcare providers.
2. Continuously engage with our users to gather feedback and insights, refining our platform to better address their needs and challenges.
3. Collaborate with academic institutions, research organizations, and technology companies to stay at the forefront of advancements in AI, telehealth, and neurological disorder care.
4. Secure funding and strategic partnerships to support our growth, allowing us to scale our operations and reach a broader audience, while maintaining our commitment to affordability and accessibility.

To measure our impact and progress, we are using the following specific indicators:

1. Number of patients and caregivers using the Polly platform: This is a key indicator of our reach and impact on our target population. By monitoring the growth in the number of users, we can assess the extent to which our solution is being adopted and positively affecting people's lives.

2. Patient and caregiver satisfaction scores: By regularly collecting feedback from our users, we can evaluate the effectiveness of our platform in meeting their needs and improving their quality of life. This will help us understand areas that may need improvement and iterate our solution accordingly.

3. Reduction in hospitalizations and emergency room visits: One of our primary goals is to improve the management of neurological disorders, ultimately reducing the need for hospitalizations and emergency care. By tracking this data, we can measure the effectiveness of our platform in achieving better health outcomes for our users.

4. Time and cost savings for patients and caregivers: By providing a comprehensive and accessible care management solution, we aim to save time and reduce costs associated with managing neurological disorders. 

5. Number of partnerships established: As we aim to collaborate with healthcare providers, governments, academic institutions, and other stakeholders, tracking the number of partnerships formed will help us assess our progress in establishing a robust network to support our solution.

6. Geographic reach and expansion: Monitoring the expansion of our solution into new regions, both nationally and internationally.

By regularly collecting and analyzing data related to these indicators, we can continuously evaluate our progress towards our impact goals, make data-driven decisions, and refine our strategies to ensure the maximum positive impact on the lives of patients with neurological disorders and their caregivers.

Our solution primarily addresses the following UN Sustainable Development Goals (SDGs):

1. SDG 3: Good Health and Well-being - Parrots Inc.'s innovative platform, Polly, directly contributes to improving the health and well-being of patients with neurological disorders and their caregivers. By offering a comprehensive care management solution that combines AI, telehealth, and personalized interventions, we help enhance the accessibility and quality of healthcare services for this vulnerable population.

2. SDG 9: Industry, Innovation, and Infrastructure - By combining multiple devices and services into a single platform, we enable a more efficient and effective approach to managing neurological disorders, fostering innovation in the sector.

3. SDG 10: Reduced Inequalities - Polly aims to bridge the gap in access to quality healthcare for underserved communities, including those in fragile contexts, rural areas, and low-income populations. By providing an affordable, accessible, and user-friendly platform, we help ensure that people with neurological disorders receive the care they need, regardless of their location or socioeconomic background.

4. SDG 17: Partnerships for the Goals - Parrots Inc. is committed to establishing partnerships with healthcare providers, governments, academic institutions, and other stakeholders to expand the reach and impact of our solution. By collaborating with these entities, we can share knowledge, resources, and expertise to drive innovation and positive change in the neurological disorder care landscape.

Our theory of change for Parrots Inc. focuses on how our integrated platform, Polly, can improve the lives of patients with neurological disorders and their caregivers by simplifying care management and enhancing the quality of care. The logical framework for our theory of change includes the following elements:

1. Activities: We develop and improve the Polly platform, incorporating AI/ML, telehealth, and IoT technology to create a comprehensive care management solution. We also establish partnerships with healthcare providers, government agencies, and other relevant stakeholders to ensure accessibility and support for our solution.

2. Immediate Outputs: By providing an all-in-one platform for care management, we can streamline the process of tracking, monitoring, and managing neurological disorders. This leads to increased adoption of the Polly platform, improved communication and collaboration among patients, caregivers, and healthcare providers, and the integration of telehealth services for remote consultations and support.

3. Short-term Outcomes: As a result of these outputs, we expect to see a reduction in the time and effort required for care management, improved patient adherence to treatment plans, and increased patient and caregiver satisfaction. Additionally, we anticipate that the platform will facilitate early detection of potential health issues and enable more timely interventions, ultimately leading to better health outcomes.

4. Long-term Outcomes: In the long run, we expect our solution to significantly improve the quality of life for patients with neurological disorders and their caregivers. This will be achieved through a reduction in hospitalizations, emergency room visits, and healthcare costs, as well as enhanced mental health and well-being for both patients and caregivers.

Our theory of change is supported by evidence from various sources, including third-party research on the effectiveness of telehealth, AI/ML, and IoT technologies in healthcare; findings from user feedback and evaluations of our platform; and data from interviews with our target population. By continuously monitoring our progress and refining our solution based on these insights, we aim to maximize our impact on the lives of patients with neurological disorders and their caregivers.

The core technology that powers Parrots Inc.'s solution, Polly, is a combination of cutting-edge and traditional technologies designed to address the complex needs of patients with neurological disorders and their caregivers. Our technology stack includes:

1. Artificial Intelligence (AI) and Machine Learning (ML): Polly leverages AI/ML algorithms to analyze patient data, identify patterns, and provide personalized insights and recommendations. This enables better decision-making, early detection of potential health issues, and optimized care management.

2. Telehealth Services: Polly incorporates telehealth functionalities, allowing remote consultations, support, and monitoring of patients by healthcare professionals. This reduces the need for in-person visits, saves time and resources, and ensures continuity of care even in remote or underserved areas.

3. Internet of Things (IoT) Integration: Our platform integrates with various IoT devices, such as wearables and smart home sensors, to collect real-time data on patients' health and daily activities. This data enables continuous monitoring and assessment, leading to more accurate and timely interventions.

4. Cloud Computing: Polly uses cloud-based infrastructure to store and manage patient data securely and efficiently. This allows for seamless data sharing among patients, caregivers, and healthcare providers, facilitating better collaboration and coordination in care management.

5. User Interface and Experience (UI/UX) Design: We prioritize human-centered design principles in developing the Polly platform. Our UI/UX design ensures that the platform is accessible, user-friendly, and engaging for patients, caregivers, and healthcare professionals alike.

6. Traditional and Ancestral Knowledge Systems: While our platform primarily employs modern technologies, we also recognize the value of traditional and ancestral knowledge systems. We incorporate relevant practices, such as mindfulness and relaxation techniques, into our care management strategies to promote holistic well-being.

By harnessing this blend of technologies, Parrots Inc. aims to provide an innovative, comprehensive, and effective solution for managing neurological disorders, ultimately improving the lives of patients and their caregivers.

Parrots Inc. has rigorously tested and validated the effectiveness of our technology through various channels to ensure its reliability and efficacy in addressing the needs of patients with neurological disorders and their caregivers. Some of the key indicators of our technology's success include:

1. Pilot studies: We have conducted pilot studies with a diverse group of patients and caregivers to evaluate the usability, functionality, and impact of our technology. These studies have demonstrated improvements in patient outcomes, reduced time to diagnosis, and increased caregiver satisfaction.

2. Real-world application: Our technology is currently being used by healthcare providers, patients, and caregivers, which serves as an ongoing validation of its effectiveness. User feedback and success stories further support the positive impact of our technology on patients' lives.

3. Research collaborations: Parrots Inc. has partnered with renowned institutions, such as Novartis, Verizon, Harvard, and many Hospitals, to conduct research on the effectiveness of our technology. These collaborations have resulted in peer-reviewed publications that provide evidence of the technology's potential in improving patient care for neurological disorders.

4. Independent evaluations: Our technology has undergone evaluations by independent experts and organizations that have assessed its effectiveness, scalability, and potential for impact. These evaluations provide additional evidence of the technology's success in addressing the needs of our target population.

While we cannot share specific academic papers at this time due to confidentiality concerns, we can assure you that our technology has been thoroughly tested and validated through various channels. We are committed to continuously refining and improving our solution based on ongoing research, user feedback, and emerging technologies to ensure that we provide the best possible care for patients with neurological disorders and their caregivers.

Here are very links and articles to tell you more about us:
- https://www.wired.com/sponsore...
- https://www.businessinsider.co...
- https://techcrunch.com/unified...
- https://www.flyparrots.com/new...

- https://www.eastersealstech.co...

- https://www.flyparrots.com/new...

- https://www.wirelessfoundation...

At Parrots Inc., we recognize the importance of diversity, equity, and inclusivity in driving innovation, fostering creativity, and ensuring the effectiveness of our solutions. Our approach to incorporating these values into our work is multifaceted and involves the following key aspects:

1. Diverse leadership and team: Our leadership team and staff come from a wide range of backgrounds, including different genders, ethnicities, and professional experiences. This diversity helps us bring varied perspectives to the table when making decisions and designing solutions, ultimately leading to more inclusive and effective outcomes for our target population.

2. Inclusive solution design: We actively involve our target communities in the design and development of our technology. By engaging patients with neurological disorders and their caregivers throughout the process, we ensure that our solution addresses their needs and is accessible and useful to a diverse range of users.

3. Equity-focused partnerships: We collaborate with organizations and institutions that share our commitment to diversity, equity, and inclusivity. These partnerships allow us to learn from and support each other in our efforts to create more equitable and inclusive solutions for our target communities.

4. Continuous improvement: We regularly assess our internal policies, practices, and culture to identify areas where we can improve our commitment to diversity, equity, and inclusivity. This includes providing ongoing training and professional development opportunities for our team to ensure that they have the necessary skills and understanding to contribute to our inclusive culture.

5. Accountability: We hold ourselves accountable for our diversity, equity, and inclusivity efforts by setting measurable goals and regularly evaluating our progress. This helps us stay on track in our mission to create a more diverse, equitable, and inclusive organization.

Our business model at Parrots Inc. is designed to create value for our target population, patients with neurological disorders and their caregivers, while generating sustainable revenue to support our mission. The key components of our business model include:

1. Product Offering: We provide a comprehensive telehealth solution, including the Polly AI-powered software platform and the optional Parrot device, designed to facilitate remote monitoring, diagnostics, and therapy for patients with neurological disorders. Our software integrates with existing medical devices and consolidates their functionalities, making it more accessible and cost-effective for our users.

2. Customer Segments: Our primary customer segments include healthcare providers (such as hospitals, clinics, and telehealth platforms), insurance companies, and individual patients and their caregivers. We tailor our offerings to suit the unique needs of each customer segment.

3. Revenue Streams: We generate revenue through a combination of software licensing fees, subscription plans, and device sales. Healthcare providers and insurance companies pay licensing fees to integrate our software into their systems, while individual patients and caregivers can choose from various subscription plans based on their needs. The optional Parrot device is sold separately, providing an additional revenue stream.

4. Value Proposition: Our solution offers multiple benefits to our customers, including improved patient outcomes, cost savings, increased accessibility to care, and enhanced patient engagement. By providing a comprehensive telehealth platform that consolidates multiple devices and facilitates remote care, we address the challenges faced by patients with neurological disorders and their caregivers, ultimately improving their quality of life.

5. Distribution Channels: We leverage partnerships with healthcare providers, insurance companies, and patient advocacy groups to distribute our solution to the target population. We also employ a targeted marketing strategy to raise awareness of our offerings among patients and caregivers.

6. Customer Relationships: We prioritize building long-term relationships with our customers, offering excellent customer support and continuously updating and improving our solution based on feedback from our users.

By focusing on creating value for our customers and beneficiaries while generating sustainable revenue, our business model supports the growth and success of our company and ensures that we can continue to make a positive impact on the lives of patients with neurological disorders and their caregivers.

Our plan for achieving financial sustainability involves a combination of diversified revenue streams, strategic partnerships, and targeted marketing efforts to drive adoption of our solution. Here's a breakdown of our approach:

1. Diversified Revenue Streams: Our primary revenue sources include software licensing fees, subscription plans, and sales of the optional Parrot device. By offering a range of pricing options and plans, we can cater to different customer segments, from healthcare providers and insurance companies to individual patients and their caregivers. This diversified revenue model ensures a steady cash flow to support our operations and growth.

2. Strategic Partnerships: We plan to form strategic partnerships with healthcare providers, insurance companies, and patient advocacy groups to increase the adoption of our solution. These partnerships not only create additional distribution channels but also help validate our offering, attracting more customers and generating more revenue.

3. Targeted Marketing: We will invest in targeted marketing efforts to raise awareness of our solution among patients, caregivers, and healthcare professionals. This includes utilizing digital marketing channels, such as social media and content marketing, as well as participating in industry events and conferences. By increasing the visibility of our solution, we aim to drive customer acquisition and revenue growth.

4. Grants funding: While we aim to become primarily self-sustaining through our revenue streams, we will also explore opportunities for grants and donations from organizations focused on improving healthcare outcomes and supporting patients with neurological disorders. This additional funding can help support our research and development efforts and further enhance our solution.

5. Cost Optimization: We plan to optimize our operational costs by employing lean methodologies and continuously evaluating our processes to identify areas for improvement. By keeping our costs in check, we can achieve better financial sustainability.

6. Investment Capital: As our business grows, we may seek additional investment capital from strategic investors who share our vision and can provide valuable expertise and resources to support our expansion.

By implementing this multi-faceted approach to financial sustainability, we will ensure that our solution continues to have a positive impact on the lives of patients with neurological disorders and their caregivers, while maintaining the long-term viability of our business.

We have already achieved some notable milestones in our pursuit of financial sustainability:

1. Seed Funding: We successfully raised an initial seed funding round from a combination of angel investors, validating the potential of our solution and providing us with the capital needed to develop our product and initiate pilot programs.

2. Grants: We have received grants and awards from foundations, governments, and many organizations, which support innovation in healthcare technology, particularly for rare diseases and neurological disorders. This grant has allowed us to further our research and development efforts.

3. Pilot Programs: We have initiated pilot programs with three prominent healthcare providers, generating early revenue and allowing us to refine our offering based on real-world user feedback. These pilot programs have resulted in positive outcomes, and we are in discussions to expand our offering to their broader networks.

4. Partnership Agreements: We have secured partnership agreements with two major insurance companies to include our solution in their coverage plans, creating an additional revenue stream and increasing the accessibility of our offering to patients.

5. Device Sales: In the initial phase of our product launch, we have sold over 500 units of the optional Parrot device, generating significant revenue and demonstrating strong demand for our integrated solution.

6. Subscription Growth (Only SaaS): Our subscription-based revenue model has shown promising growth, with an increasing number of individual patients and caregivers opting for our software solution. This recurring revenue stream contributes to our long-term financial stability.

7. Insurance Reimbursement: We have worked diligently with insurance companies to ensure that our solution is eligible for reimbursement. This not only makes our offering more affordable and accessible to patients but also contributes to our revenue stream as more patients utilize our services.

These early successes validate our approach to achieving financial sustainability and demonstrate the potential of our solution to create a positive impact on the lives of patients with neurological disorders and their caregivers. We will continue to build upon these achievements, refining our offering and expanding our reach to maximize our impact and financial sustainability.